Austin Spadaro

Mr. Austin Spadaro


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2024 in Information
Verified
Journal Article
Open access
PDF file
SASayed Mehedi Azim
Sayed Mehedi Azim
ASAustin Spadaro
Austin Spadaro
JKJoseph Kawash
Joseph Kawash
JPJames Polashock
James Polashock
ADAbdollah Dehzangi
Abdollah Dehzangi
Cranberries, native to North America, are known for their nutritional value and human health benefits. One hurdle to commercial production is losses due to fruit rot. Cranberry fruit rot results from a complex of more than ten filamentous fungi, challenging breeding for resistance. Nonetheless, our collaborative breeding program has fruit rot resistance as a significant target. This program currently relies heavily on manual sorting of sound vs. rotten cranberries. This process is labor-intensive and time-consuming, prompting the need for an automated classification (sound vs. rotten) system. Although many studies have focused on classifying different fruits and vegetables, no such approach has been developed for cranberries yet, partly because datasets are lacking for conducting the necessary image analyses. This research addresses this gap by introducing a novel image dataset comprising sound and rotten cranberries to facilitate computational analysis. In addition, we developed CARP (Cranberry Assessment for Rot Prediction), a convolutional neural network (CNN)-based model to distinguish sound cranberries from rotten ones. With an accuracy of 97.4%, a sensitivity of 97.2%, and a specificity of 97.2% on the training dataset and 94.8%, 95.4%, and 92.7% on the independent dataset, respectively, our proposed CNN model shows its effectiveness in accurately differentiating between sound and rotten cranberries.

21 February 2026 in Molecules
Verified
Journal Article
Open access
PDF file
ASAustin Spadaro
Austin Spadaro
Alok SharmaAlok Sharma
Alok Sharma
IDIman Dehzangi
Iman Dehzangi
TP53 is a tumor-suppressor gene involved in regulating apoptosis, DNA repair, and genomic stability. Mutations in TP53 are implicated in approximately half of all detected cancers, including breast, lung, colorectal, and ovarian cancers, making it a significant target for therapeutic interventions. Many pharmaceutical drugs aim to restore TP53 function, and there is a need for predictive tools to assess how compounds may affect TP53 expression. In this study, we propose a new ensemble machine-learning model to predict the direction of TP53 relative gene expression in response to pharmaceutical compounds. Our model utilizes molecular fingerprints, descriptors, and scaffold-based features extracted from SMILES representations of compounds concatenated into a single feature vector. Trained using our newly generated benchmark dataset based on the Connectivity Map (CMap) database and addressing class imbalance with the Synthetic Minority Over-sampling Technique (SMOTE), our model achieves 62.9%, 93.9%, 40.3%, and 0.39 in terms of accuracy, sensitivity, specificity, and Matthews Correlation Coefficient (MCC), respectively. As the first-of-its-kind TP53 gene regulation prediction, our study serves as a convincing proof-of-concept that paves the way for future investigation. GenReP as a stand-alone predictor, its source code, and our newly generated benchmark dataset are publicly available.